Hana Cho

 

Hana Cho was born in 1991 in Seoul, Korea. She received her B.S. and M.S. degree in Life Science at Chung-Ang University, Korea. She has joined our group in fall, 2018. She is now in Doctor’s course at Department of Biophysics and Chemical Biology (BpCB) at Seoul National University.

She is interested in exploration of biological pathway related to Alzheimer’s disease using bioactive small molecules.

Cho, H.; Choi, B. Y.; Shin, Y. -H.; Park, S. B.* ACS Chem. Neurosci. 2023, 14(23), 4139-4152.
Neuroinflammation-modulating agent SB1617 enhances LC3-associated phagocytosis to mitigate tau pathology.

Jung, J.; Park, J.; Kim, M.; Ha, J.; Cho, H.; Park, S. B.* Commun. Biol. 2023, 6(1), 300.
SB2301-mediated perturbation of membrane composition in lipid droplets induces lipophagy and lipid droplets ubiquitination.

Shin, Y. -H.; Cho, H.; Choi, B. Y.; Kim, J.; Ha, J.; Suh, S. W.; Park, S. B.* Angew. Chem. Int. Ed. 2021, 60(4), 1831-1838.
Phenotypic Discovery of Neuroprotective Agents by Regulation of Tau Proteostasis via Stress-Responsive Activation of PERK Signaling.

Hahm, J. Y.; Kim, J. Y.; Park, J. W.; Kang, J. Y.; Kim, K. B.; Kim. S. R.; Cho, H.; Seo, S. B.* Nucleic Acids Res. 2019, 47(1), 184-196.
Methylation of UHRF1 by SET7 is essential for DNA double-strand break repair.

Kang, J. Y.; Kim, J. Y.; Kim, K. B.; Park, J. W.; Cho, H.; Hahm, J. Y.; Chae, Y.C.; Kim, D.; Kook, H.; Rhee, S.; Ha, N.C.; Seo, S. B.* The FASEB Journal 2018, fj-201800242R.
KDM2B is a histone H3K79 demethylase and induces transcriptional repression via sirtuin-1–mediated chromatin silencing.

Park, J. W.; Cho, H.; Oh, H.; Kim, J. Y.; Seo, S. B.* Molecules and cells 2018, 41(5), 444.
AURKA Suppresses Leukemic THP-1 Cell Differentiation through Inhibition of the KDM6B Pathway.